234 related articles for article (PubMed ID: 2890093)
1. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase.
Brüne B; Ullrich V
Mol Pharmacol; 1987 Oct; 32(4):497-504. PubMed ID: 2890093
[TBL] [Abstract][Full Text] [Related]
2. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
3. [Soluble platelet guanylate cyclase: significance of heme in regulating enzymatic activity and the role of the enzyme in platelet aggregation].
Severina IS
Biokhimiia; 1994 Mar; 59(3):325-39. PubMed ID: 7910045
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
Mellion BT; Ignarro LJ; Myers CB; Ohlstein EH; Ballot BA; Hyman AL; Kadowitz PJ
Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
[TBL] [Abstract][Full Text] [Related]
5. Identification of platelet inhibitor present in the melon (Cucurbitacea cucumis melo).
Altman R; Rouvier J; Weisenberger H
Thromb Haemost; 1985 Jun; 53(3):312-3. PubMed ID: 3931281
[TBL] [Abstract][Full Text] [Related]
6. Effect of the polyamine-spermine on agonist-induced human platelet activation--specific inhibition of "aggregation-independent" events induced by thrombin, but not by collagen, thromboxane mimetic, phorbol ester or calcium ionophore.
Joseph S; Krishnamurthi S; Kakkar VV
Thromb Haemost; 1987 Apr; 57(2):191-5. PubMed ID: 3110996
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a new compound, S35b, as a guanylate cyclase activator in human platelets.
Ghigo D; Heller R; Calvino R; Alessio P; Fruttero R; Gasco A; Bosia A; Pescarmona G
Biochem Pharmacol; 1992 Mar; 43(6):1281-8. PubMed ID: 1348617
[TBL] [Abstract][Full Text] [Related]
8. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
[TBL] [Abstract][Full Text] [Related]
9. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
10. Carbon monoxide enhances human neutrophil migration in a cyclic GMP-dependent way.
VanUffelen BE; de Koster BM; VanSteveninck J; Elferink JG
Biochem Biophys Res Commun; 1996 Sep; 226(1):21-6. PubMed ID: 8806586
[TBL] [Abstract][Full Text] [Related]
11. Effects of ethanol on pathways of platelet aggregation in vitro.
Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
Severina IS; Belushkina NN; Grigoryev NB
Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
[TBL] [Abstract][Full Text] [Related]
13. KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism.
Lévy-Toledano S; Grelac F; Caen JP; Maclouf J
Thromb Haemost; 1995 May; 73(5):857-61. PubMed ID: 7482416
[TBL] [Abstract][Full Text] [Related]
14. 12-hydroperoxyeicosatetraenoic acid inhibits main platelet functions by activation of soluble guanylate cyclase.
Brüne B; Ullrich V
Mol Pharmacol; 1991 May; 39(5):671-8. PubMed ID: 1674588
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen binding is independent of an increase in intracellular calcium concentration in thrombin degranulated platelets.
Pulcinelli FM; Daniel JL; Riondino S; Gazzaniga PP; Salganicoff L
Thromb Haemost; 1995 Feb; 73(2):304-8. PubMed ID: 7792747
[TBL] [Abstract][Full Text] [Related]
16. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
Heinroth I; Block HU; Mest HJ
Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
[TBL] [Abstract][Full Text] [Related]
17. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
Shaw LA; Batey AJ; Coker SJ
Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
[TBL] [Abstract][Full Text] [Related]
18. Cyclic nucleotides and platelet aggregation. Effect of aggregating agents on the activity of cyclic nucleotide-metabolizing enzymes.
Barber AJ
Biochim Biophys Acta; 1976 Sep; 444(2):579-95. PubMed ID: 9149
[TBL] [Abstract][Full Text] [Related]
19. [Changes in the guanylate cyclase activity of human thrombocytes during ADP-inducible aggregation].
Chirkov IuIu; Belushkina NN; Tyshchuk IA; Severina IS
Biull Eksp Biol Med; 1991 Feb; 111(2):152-4. PubMed ID: 1677293
[TBL] [Abstract][Full Text] [Related]
20. Increase in activating ability of human platelet guanylate cyclase during aggregation.
Severina IS; Belushkina NN
Biochem Int; 1992 Dec; 28(4):621-31. PubMed ID: 1362351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]